Tandem Diabetes Care shared that its Capillary Biomedical (CapBio) subsidiary won FDA 510(k) clearance for a new infusion set.

Novo Nordisk A/S’s decision to stop making insulin pens will narrow treatment options for children with diabetes unless ...